Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-015-2334-y
Published Online: 2015-02-21
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuusisto, Milla Elvi Linnea
Haapasaari, Kirsi-Maria
Remes, Anne Marja
Bloigu, Risto
Karihtala, Peeter
Turpeenniemi-Hujanen, Taina
Kuittinen, Outi
License valid from 2015-02-21